Synageva BioPharma (GEVA - Get Report) is a clinical stage biopharmaceutical company engaged in the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical needs. This stock is trading up 4.7% at $38.50 in recent trading.
Today's Volume: 200,000Average Volume: 63,416 Volume % Change: 282% From a technical perspective, GEVA has started to flirt with a major breakout trade today now that this stock has tested some near-term overhead resistance at $39.10 on strong volume. At last check, the high of the day for GEVA is $39.33 and volume is well above its average action. Traders should now look for long biased trades in GEVA if it can manage to sustain a high-volume move and close above $39.10. If we get that action today or soon, then look for GEVA to make a run at $45 in the near future.